Glimepiride
Product Images NDC 70934-173

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 70934-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 173 90 Master Bottle Label Approval Rev A 09 19

70934 173 90 Master Bottle Label Approval Rev A 09 19
Glimepiride Tablets USP 4mg label for a 90-tablet bottle from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label includes dosage instructions, storage conditions at 25°C (77°F), Rx only designation, and a 2D barcode. It also features peel-back panels with NDC, manufacturing, and expiration details.*
FDA Label Image

Structure (Glimepiride Structure)

Structure (Glimepiride Structure)
Chemical structure of glimepiride depicting its molecular arrangement including the cyclohexyl, sulfonyl, and amide groups connected by aromatic and aliphatic linkages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.